speb/financial-data huggingface dataset:
DIVI.L balance_sheet (quarterly, 2025-05-31) — Accounts Payable: 2304000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Additional Paid In Capital: 152000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Additional Paid In Capital: 152000.00
DIVI.L income_statement (annual, 2025-05-31) — Basic Average Shares: 236393165.00
DIVI.L income_statement (annual, 2025-05-31) — Basic EPS: 0.12
DIVI.L cash_flow (annual, 2025-05-31) — Beginning Cash Position: 17027000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Capital Stock: 286000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Capital Stock: 286000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Cash And Cash Equivalents: 6282000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Cash And Cash Equivalents: 6282000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Cash Cash Equivalents And Federal Funds Sold: 6282000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Cash Cash Equivalents And Federal Funds Sold: 6282000.00
DIVI.L cash_flow (annual, 2025-05-31) — Cash Dividends Paid: -10165000.00
DIVI.L cash_flow (annual, 2025-05-31) — Change In Other Current Liabilities: 0.00
DIVI.L cash_flow (annual, 2025-05-31) — Change In Payable: 240000.00
DIVI.L cash_flow (annual, 2025-05-31) — Change In Receivables: 713000.00
DIVI.L cash_flow (annual, 2025-05-31) — Change In Working Capital: 953000.00
DIVI.L cash_flow (annual, 2025-05-31) — Changes In Cash: -10745000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Common Stock: 286000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Common Stock: 286000.00
DIVI.L cash_flow (annual, 2025-05-31) — Common Stock Dividend Paid: -10165000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Common Stock Equity: 252217000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Common Stock Equity: 252217000.00
DIVI.L cash_flow (annual, 2025-05-31) — Common Stock Payments: -77925000.00
DIVI.L income_statement (annual, 2025-05-31) — Diluted Average Shares: 236393165.00
DIVI.L income_statement (annual, 2025-05-31) — Diluted EPS: 0.12
DIVI.L income_statement (annual, 2025-05-31) — Diluted NI Availto Com Stockholders: 28694000.00
DIVI.L cash_flow (annual, 2025-05-31) — End Cash Position: 6282000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 246479000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 246479000.00
DIVI.L cash_flow (annual, 2025-05-31) — Financing Cash Flow: -88119000.00
DIVI.L cash_flow (annual, 2025-05-31) — Free Cash Flow: 11103000.00
DIVI.L cash_flow (annual, 2025-05-31) — Gain Loss On Investment Securities: -18544000.00
DIVI.L income_statement (annual, 2025-05-31) — Gain On Sale Of Security: 18544000.00
DIVI.L income_statement (annual, 2025-05-31) — General And Administrative Expense: 835000.00
DIVI.L income_statement (annual, 2025-05-31) — Interest Income: 969000.00
DIVI.L cash_flow (annual, 2025-05-31) — Investing Cash Flow: 66271000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Investmentin Financial Assets: 246479000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Investmentin Financial Assets: 246479000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Investments And Advances: 246479000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Investments And Advances: 246479000.00
DIVI.L cash_flow (annual, 2025-05-31) — Net Common Stock Issuance: -77925000.00
DIVI.L income_statement (annual, 2025-05-31) — Net Income: 28694000.00
DIVI.L income_statement (annual, 2025-05-31) — Net Income Common Stockholders: 28694000.00
DIVI.L income_statement (annual, 2025-05-31) — Net Income Continuous Operations: 28694000.00
DIVI.L income_statement (annual, 2025-05-31) — Net Income From Continuing And Discontinued Operation: 28694000.00
DIVI.L income_statement (annual, 2025-05-31) — Net Income From Continuing Operation Net Minority Interest: 28694000.00
DIVI.L cash_flow (annual, 2025-05-31) — Net Income From Continuing Operations: 28828000.00
DIVI.L income_statement (annual, 2025-05-31) — Net Income Including Noncontrolling Interests: 28694000.00
DIVI.L income_statement (annual, 2025-05-31) — Net Interest Income: 969000.00
DIVI.L cash_flow (annual, 2025-05-31) — Net Investment Purchase And Sale: 66271000.00
DIVI.L cash_flow (annual, 2025-05-31) — Net Other Financing Charges: -29000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Net Tangible Assets: 252217000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Net Tangible Assets: 252217000.00
DIVI.L income_statement (annual, 2025-05-31) — Normalized Income: 28694000.00
DIVI.L cash_flow (annual, 2025-05-31) — Operating Cash Flow: 11103000.00
DIVI.L income_statement (annual, 2025-05-31) — Operating Revenue: 29663000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Ordinary Shares Number: 236393165.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Ordinary Shares Number: 236393165.00
DIVI.L balance_sheet (annual, 2025-05-31) — Payables: 2304000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Payables: 2304000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Prepaid Assets: 105000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Prepaid Assets: 105000.00
DIVI.L income_statement (annual, 2025-05-31) — Pretax Income: 28828000.00
DIVI.L cash_flow (annual, 2025-05-31) — Purchase Of Investment: -71308000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Receivables: 1618000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Receivables: 1618000.00
DIVI.L cash_flow (annual, 2025-05-31) — Repurchase Of Capital Stock: -77925000.00
DIVI.L cash_flow (annual, 2025-05-31) — Sale Of Investment: 137579000.00
DIVI.L income_statement (annual, 2025-05-31) — Selling General And Administration: 835000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Share Issued: 236393165.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Share Issued: 236393165.00
DIVI.L balance_sheet (annual, 2025-05-31) — Stockholders Equity: 252217000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Stockholders Equity: 252217000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Tangible Book Value: 252217000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Tangible Book Value: 252217000.00
DIVI.L income_statement (annual, 2025-05-31) — Tax Effect Of Unusual Items: 0.00
DIVI.L income_statement (annual, 2025-05-31) — Tax Provision: 134000.00
DIVI.L income_statement (annual, 2025-05-31) — Tax Rate For Calcs: 0.00
DIVI.L balance_sheet (annual, 2025-05-31) — Taxes Receivable: 37000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Taxes Receivable: 37000.00
DIVI.L cash_flow (annual, 2025-05-31) — Taxes Refund Paid: -134000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Total Assets: 254521000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Total Assets: 254521000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Total Equity Gross Minority Interest: 252217000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Total Equity Gross Minority Interest: 252217000.00
DIVI.L balance_sheet (annual, 2025-05-31) — Total Liabilities Net Minority Interest: 2304000.00
DIVI.L balance_sheet (quarterly, 2025-05-31) — Total Liabilities Net Minority Interest: 2304000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Accounts Payable: 3041000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Additional Paid In Capital: 225000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Capital Stock: 213000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Cash And Cash Equivalents: 82855000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Cash Cash Equivalents And Federal Funds Sold: 82855000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Common Stock: 213000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Common Stock Equity: 185186000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 180762000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Investmentin Financial Assets: 180762000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Investments And Advances: 180762000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Net Tangible Assets: 185186000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Ordinary Shares Number: 163570773.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Payables: 3041000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Receivables: 3854000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Share Issued: 163570773.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Stockholders Equity: 185186000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Tangible Book Value: 185186000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Total Assets: 267471000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Total Equity Gross Minority Interest: 185186000.00
DIVI.L balance_sheet (quarterly, 2025-11-30) — Total Liabilities Net Minority Interest: 82285000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Accumulated Depreciation: -12815200000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Additional Paid In Capital: 798800000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Allowance For Doubtful Accounts Receivable: -51200000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Amortization: 31800000.00
DIVISLAB.NS cash_flow (annual, 2022-03-31) — Amortization Cash Flow: 31800000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Buildings And Improvements: 53000000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Cash Equivalents: 11928800000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Cash Financial: 218800000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Current Deferred Taxes Liabilities: 68000000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Current Provisions: 41500000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Dividends Payable: 10700000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 720100000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Finished Goods: 3191500000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — General And Administrative Expense: 1084600000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Gross Accounts Receivable: 24290000000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Interest Income: 689600000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Interest Income Non Operating: 689600000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Land And Improvements: 16077600000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Long Term Provisions: 267100000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Machinery Furniture Equipment: 37688400000.00
DIVISLAB.NS cash_flow (annual, 2022-03-31) — Net Issuance Payments Of Debt: -3500000.00
DIVISLAB.NS cash_flow (annual, 2022-03-31) — Net Short Term Debt Issuance: -3500000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 267100000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Non Current Prepaid Assets: 862700000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Other Intangible Assets: 74900000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Other Payable: 3683500000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Other Receivables: 26000000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Other Special Charges: 20500000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Prepaid Assets: 1178700000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Properties: 0.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Raw Materials: 9778800000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Rent And Landing Fees: 107700000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Rent Expense Supplemental: 107700000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Research And Development: 202900000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Restricted Cash: 772200000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Retained Earnings: 99888500000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Selling And Marketing Expense: 1270100000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Selling General And Administration: 2354700000.00
DIVISLAB.NS income_statement (annual, 2022-03-31) — Total Other Finance Cost: 16300000.00
DIVISLAB.NS balance_sheet (annual, 2022-03-31) — Work In Process: 15315900000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — +Operating Expense: 24600000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — +Total Revenue: 76650000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Accounts Payable: 7620000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Accounts Receivable: 17930000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Accumulated Depreciation: -16210000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Additional Paid In Capital: 800000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Allowance For Doubtful Accounts Receivable: -60000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Amortization: 40000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Amortization Cash Flow: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Available For Sale Securities: 1281400000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Basic Average Shares: 265468580.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Basic EPS: 68.69
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Beginning Cash Position: 12150000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Buildings And Improvements: 60000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Capital Expenditure: -4730000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Capital Lease Obligations: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Capital Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Cash And Cash Equivalents: 1700000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Cash Cash Equivalents And Short Term Investments: 41360000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Cash Dividends Paid: -7960000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Cash Equivalents: 1410000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Cash Financial: 290000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Change In Inventory: -1720000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Assets: 260000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Change In Other Current Liabilities: -600000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Change In Payable: -340000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Change In Receivables: 6500000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Change In Working Capital: 4190000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Changes In Cash: -10450000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Common Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Common Stock Equity: 127670000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Construction In Progress: 2310000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Cost Of Revenue: 31780000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Current Assets: 93120000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Current Capital Lease Obligation: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Current Debt: 0.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Current Debt And Capital Lease Obligation: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Current Deferred Taxes Liabilities: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Current Liabilities: 11010000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Current Provisions: 49200000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Depreciation: 3390000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Depreciation And Amortization: 3430000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Depreciation And Amortization In Income Statement: 3430000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Depreciation Income Statement: 3390000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Diluted Average Shares: 265468580.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Diluted EPS: 68.69
DIVISLAB.NS income_statement (annual, 2023-03-31) — Diluted NI Availto Com Stockholders: 18240000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Dividends Payable: 10000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — EBIT: 23690000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — EBITDA: 27120000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — End Cash Position: 1700000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 770000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Financing Cash Flow: -7970000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Finished Goods: 3020000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Free Cash Flow: 19860000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Gain Loss On Investment Securities: -40000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — General And Administrative Expense: 1260000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Goodwill And Other Intangible Assets: 50000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Gross Accounts Receivable: 17990000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Gross PPE: 65690000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Gross Profit: 44870000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Interest Expense: 0.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Interest Expense Non Operating: 0.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Interest Income: 2050000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Interest Income Non Operating: 2050000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Interest Paid Cff: 0.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Interest Received Cfi: 2050000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Inventory: 30000000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Invested Capital: 127670000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Investing Cash Flow: -27070000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Investmentin Financial Assets: 770000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Land And Improvements: 17540000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Capital Lease Obligation: 30000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Debt And Capital Lease Obligation: 30000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Long Term Provisions: 306200000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Machinery Furniture Equipment: 43340000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Minority Interests: 0.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Net Foreign Currency Exchange Gain Loss: 100000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Income: 18240000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Income Common Stockholders: 18240000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Income Continuous Operations: 18240000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing And Discontinued Operation: 18240000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Income From Continuing Operation Net Minority Interest: 18240000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Net Income From Continuing Operations: 23690000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Income Including Noncontrolling Interests: 18240000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Interest Income: 2030000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Net Investment Purchase And Sale: -24390000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Net Issuance Payments Of Debt: 0.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Net Non Operating Interest Income Expense: 2030000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Net PPE: 49480000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Net PPE Purchase And Sale: -4730000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Net Short Term Debt Issuance: 0.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Net Tangible Assets: 127620000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Assets: 140000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Deferred Taxes Liabilities: 5370000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 310000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Non Current Prepaid Assets: 790000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Normalized EBITDA: 27080000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Normalized Income: 18209202195.02
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Operating Cash Flow: 24590000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Operating Income: 20270000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Operating Revenue: 76650000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Ordinary Shares Number: 265468580.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Assets: 2017700000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Current Liabilities: 90000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Equity Interest: 127140000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Intangible Assets: 50000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Inventories: 90000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Other Non Cash Items: -2050000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Non Current Assets: 210000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Other Non Operating Income Expenses: 50000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Other Operating Expenses: 9600000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Payable: 2820000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Properties: 2440000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Receivables: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Other Short Term Investments: 39660000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Other Special Charges: 10000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Payables: 10450000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 50000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Prepaid Assets: 1610000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Pretax Income: 23690000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Properties: 0.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Provisionand Write Offof Assets: 0.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of Investment: -40400000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Purchase Of PPE: -4730000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Raw Materials: 11630000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Reconciled Cost Of Revenue: 31780000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Reconciled Depreciation: 3430000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Rent And Landing Fees: 120000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Rent Expense Supplemental: 120000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Research And Development: 300000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Restricted Cash: 810000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Retained Earnings: 109590000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Sale Of Investment: 16010000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Sale Of PPE: 0.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Selling And Marketing Expense: 1140000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Selling General And Administration: 2400000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Share Issued: 265468580.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Special Income Charges: -10000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Stockholders Equity: 127670000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Tangible Book Value: 127620000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Tax Effect Of Unusual Items: 9202195.02
DIVISLAB.NS income_statement (annual, 2023-03-31) — Tax Provision: 5450000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Tax Rate For Calcs: 0.23
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Taxes Receivable: 1390000000.00
DIVISLAB.NS cash_flow (annual, 2023-03-31) — Taxes Refund Paid: -4730000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Assets: 144390000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Capitalization: 127670000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Debt: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Equity Gross Minority Interest: 127670000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Total Expenses: 56380000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Liabilities Net Minority Interest: 16720000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Assets: 51270000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Non Current Liabilities Net Minority Interest: 5710000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Total Other Finance Cost: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Total Tax Payable: -60000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items: 40000000.00
DIVISLAB.NS income_statement (annual, 2023-03-31) — Total Unusual Items Excluding Goodwill: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Work In Process: 15260000000.00
DIVISLAB.NS balance_sheet (annual, 2023-03-31) — Working Capital: 82110000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — +Operating Expense: 26950000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — +Total Revenue: 77960000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Payable: 8240000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Accounts Receivable: 21560000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Accumulated Depreciation: -19960000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Additional Paid In Capital: 800000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Allowance For Doubtful Accounts Receivable: -100000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Amortization: 30000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Amortization Cash Flow: 30000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Available For Sale Securities: 1380000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Basic Average Shares: 265468580.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Basic EPS: 60.27
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Beginning Cash Position: 1700000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Buildings And Improvements: 60000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Capital Expenditure: -10030000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Capital Lease Obligations: 30000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Capital Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Cash And Cash Equivalents: 3630000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Cash Cash Equivalents And Short Term Investments: 37010000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Cash Dividends Paid: -7960000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Cash Equivalents: 3400000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Cash Financial: 230000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Change In Inventory: -1840000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Assets: -1320000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Change In Other Current Liabilities: 20000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Change In Payable: 620000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Change In Receivables: -3610000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Change In Working Capital: -6070000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Changes In Cash: 1930000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock: 530000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Common Stock Equity: 135710000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Construction In Progress: 8970000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Cost Of Revenue: 32690000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Current Assets: 96750000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Current Capital Lease Obligation: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt: 0.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Current Debt And Capital Lease Obligation: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Current Deferred Taxes Liabilities: 430000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Current Liabilities: 12780000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Current Provisions: 70000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Depreciation: 3750000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Depreciation And Amortization: 3780000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Depreciation And Amortization In Income Statement: 3780000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Depreciation Income Statement: 3750000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Diluted Average Shares: 265468580.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Diluted EPS: 60.27
DIVISLAB.NS income_statement (annual, 2024-03-31) — Diluted NI Availto Com Stockholders: 16000000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Dividends Payable: 10000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — EBIT: 21660000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — EBITDA: 25440000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — End Cash Position: 3630000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Financial Assets Designatedas Fair Value Through Profitor Loss Total: 820000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Financing Cash Flow: -7990000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Finished Goods: 3170000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Free Cash Flow: 2580000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Investment Securities: -50000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Gain Loss On Sale Of PPE: 40000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — General And Administrative Expense: 1250000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Goodwill And Other Intangible Assets: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Gross Accounts Receivable: 21660000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Gross PPE: 76280000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Gross Profit: 45270000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Interest Expense: 30000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Interest Expense Non Operating: 30000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Interest Income: 3010000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Interest Income Non Operating: 3010000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Interest Paid Cff: -20000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Interest Received Cfi: 3000000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Inventory: 31840000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Invested Capital: 135710000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Investing Cash Flow: -2690000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Investmentin Financial Assets: 820000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Land And Improvements: 18620000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Long Term Provisions: 370000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Machinery Furniture Equipment: 46070000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Minority Interests: 0.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Net Foreign Currency Exchange Gain Loss: -20000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Income: 16000000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Income Common Stockholders: 16000000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Income Continuous Operations: 16000000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing And Discontinued Operation: 16000000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Income From Continuing Operation Net Minority Interest: 16000000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Net Income From Continuing Operations: 21630000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Income Including Noncontrolling Interests: 16000000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Interest Income: 2970000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Net Investment Purchase And Sale: 4340000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Net Issuance Payments Of Debt: 0.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Net Non Operating Interest Income Expense: 2970000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Net PPE: 56320000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Net PPE Purchase And Sale: -10030000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Net Short Term Debt Issuance: 0.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Net Tangible Assets: 135670000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Assets: 100000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Deferred Taxes Liabilities: 5820000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Pension And Other Postretirement Benefit Plans: 370000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Non Current Prepaid Assets: 580000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Normalized EBITDA: 25430000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Normalized Income: 15992602866.39
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Operating Cash Flow: 12610000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Operating Income: 18320000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Operating Revenue: 77960000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Ordinary Shares Number: 265468580.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Assets: 3200000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Current Liabilities: 310000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Equity Interest: 135180000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Intangible Assets: 40000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Inventories: 80000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Other Non Cash Items: -2980000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Non Current Assets: 1290000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Other Non Operating Income Expenses: 30000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Other Operating Expenses: 10080000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Payable: 3360000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Properties: 2620000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Receivables: 20000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Other Short Term Investments: 33380000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Other Special Charges: 40000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Otherunder Preferred Stock Dividend: 0.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Payables: 12040000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Pensionand Other Post Retirement Benefit Plans Current: 70000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Prepaid Assets: 1470000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Pretax Income: 21630000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Properties: 0.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Provisionand Write Offof Assets: 40000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of Investment: -35150000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Purchase Of PPE: -10030000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Raw Materials: 12390000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Reconciled Cost Of Revenue: 32690000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Reconciled Depreciation: 3780000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Rent And Landing Fees: 120000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Rent Expense Supplemental: 120000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Research And Development: 350000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Restricted Cash: 2820000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Retained Earnings: 117860000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Sale Of Investment: 39490000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Sale Of PPE: 0.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Selling And Marketing Expense: 900000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Selling General And Administration: 2150000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Share Issued: 265468580.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Special Income Charges: -40000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Stockholders Equity: 135710000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Tangible Book Value: 135670000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Tax Effect Of Unusual Items: 2602866.39
DIVISLAB.NS income_statement (annual, 2024-03-31) — Tax Provision: 5630000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Tax Rate For Calcs: 0.26
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Taxes Receivable: 2030000000.00
DIVISLAB.NS cash_flow (annual, 2024-03-31) — Taxes Refund Paid: -3760000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Assets: 154700000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Capitalization: 135710000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Debt: 30000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Equity Gross Minority Interest: 135710000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Total Expenses: 59640000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Liabilities Net Minority Interest: 18990000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Assets: 57950000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Non Current Liabilities Net Minority Interest: 6210000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Total Other Finance Cost: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Total Tax Payable: 430000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items: 10000000.00
DIVISLAB.NS income_statement (annual, 2024-03-31) — Total Unusual Items Excluding Goodwill: 10000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Treasury Shares Number: 0.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Work In Process: 16200000000.00
DIVISLAB.NS balance_sheet (annual, 2024-03-31) — Working Capital: 83970000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Payable: 8550000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Accounts Receivable: 21810000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 1470000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Lease Obligations: 30000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Capital Stock: 530000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash And Cash Equivalents: 380000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Cash Cash Equivalents And Short Term Investments: 36080000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock: 530000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Common Stock Equity: 137170000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Construction In Progress: 13160000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Assets: 93410000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Capital Lease Obligation: 10000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt: 50000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Debt And Capital Lease Obligation: 60000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Liabilities: 12910000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Current Provisions: 480000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Goodwill And Other Intangible Assets: 40000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Gross PPE: 59700000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Inventory: 31450000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Invested Capital: 137220000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 1470000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Long Term Debt And Capital Lease Obligation: 20000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Net PPE: 59700000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Net Tangible Assets: 137130000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Assets: 150000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Non Current Deferred Taxes Liabilities: 5760000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Ordinary Shares Number: 265468580.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Assets: 3860000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Current Liabilities: 2490000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Equity Interest: 136640000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Non Current Assets: 1010000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Properties: 46540000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Other Short Term Investments: 35700000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Payables: 9230000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Share Issued: 265468580.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Stockholders Equity: 137170000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Tangible Book Value: 137130000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Taxes Receivable: 210000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Assets: 155860000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Capitalization: 137170000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Debt: 80000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Equity Gross Minority Interest: 137170000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Liabilities Net Minority Interest: 18690000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Assets: 62450000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Non Current Liabilities Net Minority Interest: 5780000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 680000000.00
DIVISLAB.NS balance_sheet (quarterly, 2024-09-30) — Working Capital: 80500000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — +Operating Expense: 7530000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — +Total Revenue: 23190000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Basic Average Shares: 265315315.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Basic EPS: 22.20
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Cost Of Revenue: 9220000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Depreciation And Amortization In Income Statement: 990000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Depreciation Income Statement: 990000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Diluted Average Shares: 265315315.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Diluted EPS: 22.20
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Diluted NI Availto Com Stockholders: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — EBIT: 7260000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — EBITDA: 8250000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Gross Profit: 13970000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Interest Expense: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Interest Expense Non Operating: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Minority Interests: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Income: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Common Stockholders: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Continuous Operations: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing And Discontinued Operation: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Income Including Noncontrolling Interests: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Interest Income: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Net Non Operating Interest Income Expense: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Normalized EBITDA: 8250000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Normalized Income: 5890000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Operating Income: 6440000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Operating Revenue: 23190000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 720000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Other Operating Expenses: 3570000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Otherunder Preferred Stock Dividend: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Pretax Income: 7260000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Reconciled Cost Of Revenue: 9220000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Reconciled Depreciation: 990000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Special Income Charges: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Tax Effect Of Unusual Items: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Tax Provision: 1370000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Tax Rate For Calcs: 0.19
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Total Expenses: 16750000000.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items: 0.00
DIVISLAB.NS income_statement (quarterly, 2024-12-31) — Total Unusual Items Excluding Goodwill: 0.00